Large-scale quaternary structural transitions underlie gain of function of SPOP cancer mutations

Matthew J Cuneo1, Ömer Güllülü1, Mohamed-Raafet Ammar1

  • 1Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Molecular Cell
|July 13, 2026
PubMed

Insights

Speckle-type POZ protein (SPOP) filaments regulate cancer by switching between active and inactive states. Activating mutations disrupt this balance, leading to uncontrolled cell growth and offering new therapeutic targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Speckle-type POZ protein (SPOP) is a crucial substrate receptor for the Cullin-3-RING (CRL3) ubiquitin ligase.
  • Mutations in SPOP are implicated in various cancers, with both activating and inactivating mutations driving oncogenesis.
  • SPOP's unique ability to form multivalent filaments for substrate binding contrasts with typical substrate receptor mechanisms.

Purpose of the Study:

  • To elucidate the regulatory mechanisms of SPOP filament assembly and substrate ubiquitination.
  • To understand how mutations in SPOP lead to oncogenic gain-of-function.
  • To explore the potential of targeting SPOP's regulatory axis for cancer therapies.

Main Methods:

  • Investigated SPOP assembly states using structural and biochemical analyses.
  • Examined the impact of activating and inactivating mutations on SPOP equilibrium and substrate turnover.
  • Analyzed the role of SPOP filament formation in cellular regulation.

Main Results:

  • SPOP assemblies exist in a dynamic equilibrium between active filaments and an autoinhibited circular 'double-donut' state.
  • Activating mutations shift this equilibrium towards the active filament state, causing aberrant substrate ubiquitination.
  • Combinations of mutations reveal a tunable regulatory axis, influencing SPOP activity levels.

Conclusions:

  • SPOP filament assembly is essential for its cellular regulation and underlies gain-of-function mechanisms in cancer.
  • Understanding the SPOP equilibrium provides insights into oncogenesis driven by SPOP mutations.
  • Targeting the SPOP regulatory axis presents a promising strategy for developing novel cancer therapies.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...